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Adaptor protein 4 (AP-4) is the most recently discov-
ered and least well-characterized member of the
family of heterotetrameric adaptor protein (AP)
complexes that mediate sorting of transmembrane
cargo in post-Golgi compartments. Herein, we report
the interaction of an YKFFE sequence from the cyto-
solic tail of the Alzheimer’s disease amyloid precursor
protein (APP) with the m4 subunit of AP-4. Biochem-
ical and X-ray crystallographic analyses reveal that
the properties of the APP sequence and the location
of the binding site on m4 are distinct from those of
other signal-adaptor interactions. Disruption of the
APP-AP-4 interaction decreases localization of APP
to endosomes and enhances g-secretase-catalyzed
cleavageofAPPto thepathogenicamyloid-bpeptide.
These findings demonstrate that APP and AP-4
engage in a distinct type of signal-adaptor interaction
that mediates transport of APP from the trans-Golgi
network (TGN) to endosomes, thereby reducing
amyloidogenic processing of the protein.
INTRODUCTION
Sorting of transmembrane proteins to post-Golgi compartments
of the endomembrane system such as endosomes, lysosomes,
lysosome-related organelles (LROs), and the basolateral surface
of polarized epithelial cells is mediated by interaction of (1)
signals in the cytosolic domains of the proteins with (2) adaptors
that are components of protein coats (reviewed by Bonifacino
and Traub, 2003). These signals are not strictly conserved
sequences but degenerate arrays of amino acids fitting one of
several consensus motifs, the most common of which are
DXXLL, [DE]XXXL[LI], NPXY, and YXXØ (where X is any amino
acid, Ø an amino acid with a bulky hydrophobic side chain,
and the rest specific amino acids denoted in single-letter code)
(Bonifacino and Traub, 2003). A diverse set of monomeric or olig-
omeric adaptors recognize these signals with specificity that is,
in most cases, dictated by the identity of the variable residues.
DXXLL and NPXY signals are recognized by monomeric GGADeveloand PTB-domain-containing clathrin adaptors, respectively
(Bonifacino and Traub, 2003). [DE]XXXL[LI] and YXXØ signals,
on the other hand, interact with the clathrin-associated, hetero-
tetrameric adaptor protein (AP) complexes AP-1 (g-b1-m1-s1),
AP-2 (a-b2-m2-s2), and AP-3 (d-b3-m3-s3) (subunit composition
in parenthesis) (Bonifacino and Traub, 2003). Biochemical anal-
yses have shown that [DE]XXXL[LI] signals bind to a combination
of two subunits (i.e., AP-1 g-s1, AP-2 a-s2, and AP-3 d-s3)
(Chaudhuri et al., 2007; Doray et al., 2007; Janvier et al., 2003),
while YXXØ signals bind to the m subunit of each AP complex
(Ohno et al., 1996; Ohno et al., 1995). The structural bases for
these interactions have been elucidated by X-ray crystallography
of AP-2 (Kelly et al., 2008; Owen and Evans, 1998). These inter-
actions produce different outcomes depending on the exact
sequence and context of the signal, as well as the localization
and function of each AP complex (Bonifacino and Traub,
2003). AP-1 has been implicated in bidirectional transport
between the trans-Golgi network (TGN) and endosomes and in
sorting to the basolateral surface of polarized epithelial cells.
AP-2 mediates rapid internalization of a subset of endocytic
receptors from the plasma membrane. Finally, AP-3 directs
proteins from endosomes to LROs such as melanosomes (Boni-
facino and Traub, 2003; Dell’Angelica, 2009).
Despite these advances in the elucidation of the mechanisms
that decode sorting signals in post-Golgi compartments, many
aspects of this system remain poorly understood. Particularly
tantalizing is the existence of a fourth AP complex, AP-4
(3-b4-m4-s4) (Dell’Angelica et al., 1999; Hirst et al., 1999), whose
function as a signal-recognition adaptor is less well established.
AP-4 is expressed in all mammalian cell types examined to date,
wherein it localizes to the TGN in an ARF-regulated manner
(Boehm et al., 2001; Dell’Angelica et al., 1999; Hirst et al.,
1999). Unlike the other AP complexes, AP-4 does not interact
with clathrin and is believed to be part of a nonclathrin coat
(Dell’Angelica et al., 1999; Hirst et al., 1999). Yeast two- and
three-hybrid (Y2H and Y3H, respectively) analyses have shown
that AP-4 does not bind most canonical YXXØ and [DE]XXXL[LI]
signals (Aguilar et al., 2001; Janvier and Bonifacino, 2005). The
only naturally occurring canonical signals known to bind to the
m4 subunit of AP-4 are YXXØ-type sequences from the lyso-
somal membrane proteins CD63 (Hirst et al., 1999), LAMP-1
(Stephens and Banting, 1998), and LAMP-2a (Aguilar et al.,
2001). However, these interactions are exceedingly weak, and
depletion of m4 has no effect on the localization of any of thesepmental Cell 18, 425–436, March 16, 2010 ª2010 Elsevier Inc. 425
Figure 1. Analysis of Interaction between APP Cytosolic Tail and m4
Subunit
(A) Schematic representation of APP indicating its topological domains (TM,
transmembrane; N, N terminus; C, C terminus); the position of the Ab peptide;
the a, b, g, and caspase cleavage sites; and the fragments produced. Under-
lined are regions in APP recognized by the antibodies used in this study.
(B) Sequence of the APP cytosolic tail indicating residue numbers, two YXXØ
motifs (solid underlines), Tyr residues (asterisks), an NPXY-type signal (dashed
underline), and key residues for interaction with m4 (dashed box).
(C–E) Y2H analysis of the interaction of the APP cytosolic tail with m4. Yeast
were cotransformed with plasmids encoding Gal4bd fused to the wild-type
or mutant APP constructs, and Gal4ad fused to the adaptor subunits. Mouse
p53 fused to Gal4bd and SV40 large T antigen (T Ag) fused to Gal4ad were
used as controls. Cotransformed cells were spotted onto His-deficient
(His) or His-containing (+His) plates and incubated at 30C.
(F) ITC of ENPTYKFFEQ peptide (black line and solid circles) or ENPTAKAAEQ
peptide (dashed line and open circles) with m4 and of ENPTYKFFEQ peptide
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et al., 2002). Other studies have shown interaction of isolated
m4 or the whole AP-4 complex with several transmembrane
proteins targeted to the basolateral surface of polarized epithe-
lial cells (Simmen et al., 2002), to the d2 orphan glutamate
receptor (Yap et al., 2003), and to the transmembrane AMPA
glutamate receptor regulatory proteins (TARPs) (Matsuda et al.,
2008). However, the exact nature of the signals involved in these
interactions and the structural basis for their recognition by AP-4
have not been defined.
We have investigated further the potential signal-recognition
function of AP-4, aiming to achieve the same level of structural
and functional understanding that is available for other signal-
adaptor interactions. Herein, we report the discovery of a specific
and robust interaction of the sequence, YKFFE, from the cyto-
solic tail of the Alzheimer’s disease (AD) amyloid precursor
protein (APP) with the C-terminal domain of the AP-4 m4 subunit.
Although the YKFFE sequence fits the minimal consensus for
YXXØ signals, mutational and binding analyses reveal unique
features that identify it as a distinct type of signal. Moreover,
X-ray crystallographic structure determination at near-atomic
resolution shows that the YKFFE sequence binds to a site on
m4 that is different from the YXXØ-binding site on the homolo-
gous m2 subunit of AP-2 (Owen and Evans, 1998). We also
show that mutation of the YKFFE sequence or depletion of m4
shifts the distribution of APP from endosomes to the trans-Golgi
network (TGN), uncovering a role for AP-4 in TGN-to-endosome
transport. Impaired transport of APP to endosomes enhances
g-secretase-catalyzed cleavage of APP to the pathogenic
amyloid-b (Ab) peptide, implying that this proteolytic event
predominantly occurs at the TGN or in the late secretory
pathway. These findings thus identify a novel type of signal-
adaptor interaction that regulates APP trafficking in a manner
that reduces amyloidogenic processing of the protein.RESULTS
An Unusual Sequence Motif Mediates Interaction
of the APP Tail with the m4 Subunit of AP-4
APP is an ubiquitously-expressed type-I transmembrane glyco-
protein with a large N-terminal extracellular domain, a single
membrane span, and a short C-terminal cytosolic tail (Figure 1A).
After synthesis in the endoplasmic reticulum (ER), APP traffics
through the secretory pathway to attain a steady-state distribu-
tion that includes the Golgi complex, the plasmamembrane, and
endosomes (Caporaso et al., 1994; Haass et al., 1992). During
transport, APP undergoes proteolytic processing through
two alternative pathways known as ‘‘nonamyloidogenic’’ and
‘‘amyloidogenic’’ (Small and Gandy, 2006). The amyloidogenic
pathway produces the 4 kDa Ab peptide (Figure 1A), which is
secreted into the extracellular space and aggregates to form
amyloid plaques, a pathogenic hallmark of AD (Small andGandy,
2006). Because the endopeptidases (i.e., ‘‘secretases’’) that
participate in each pathway have different distributions withinwith m4-R283D (gray line and circles). The Kd and stoichiometry (N) for the
m4-ENPTYKFFEQ interaction are expressed as the mean ± SEM (n = 3).
(G) Y2H analysis of the interaction of m4 with the APP cytosolic tail containing
substitutions within the YKFFE sequence.
Inc.
Figure 2. Crystal Structure of the m4 C-Terminal
Domain in Complex with a Peptide Signal from APP
(A) Ribbon representation of human m4C-terminal domain with
subdomain A in blue, subdomain B in red, and the APP peptide
(TYKFFEQ; stick model) in yellow.
(B) Superposition of m4 and rat m2 (with the EGF receptor
peptide in magenta; pdb entry 1BW8; Owen and Evans,
1998). In orange (A) is shown a loop that is disordered in m2.
The position of the N- (N, Nm2, and Nm4) and C-termini (C) are
indicated.
(C and D) Model of the AP-4 (C) and structure of the AP-2 (D)
(Collins et al., 2002; pdb entry 1GW5) core complexes
showing the position of the respective peptide-binding sites
and the PIP2–binding site on the AP-2 a subunit. See also
Figure S1.
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the amount of secreted Ab. Understanding the mechanisms that
control the intracellular trafficking of APP is thus crucial to the
elucidation of AD pathogenesis.
In the course of a study on APP trafficking, we inspected the
cytosolic tail of APP for potential sorting signals. We noticed
two YXXØ motifs (YTSI, residues 653-656; YKFF, residues
687-690) (Figure 1B, solid underlines) in addition to a previously
reported (Chen et al., 1990; Perez et al., 1999) NPXY motif
(NPTY, residues 684-687) (Figure 1B, dashed underline). The
presence of these YXXØ motifs prompted us to test for interac-
tion of the APP tail with the m subunits of the four AP complexes
using the Y2H system. Strikingly, we found that the APP tail inter-
acted exclusively with the m4 subunit of AP-4 (Figure 1C), a
unique preference that had not been previously observed for
any other cargo protein (Aguilar et al., 2001; Ohno et al., 1996;
Ohno et al., 1995). The other three subunits of AP-4 (i.e., 3, b4,
and s4) did not bind to the APP tail in this system (Figure 1C).
Further analyses revealed that the binding site for the APP tail
was on the C-terminal domain of m4 (residues 156-453 of the
human protein; Aguilar et al., 2001) (Figure 1C, m4-C).
Mutagenesis of the APP tail showed that Tyr-687 within the
YKFF sequence was the only Tyr residue that contributed, albeit
partially, to m4 binding (Figure 1D). Deletion of nine residues from
the C terminus of APP, including Tyr-687, completely abolished
binding to m4 (Figure 1D, D687-695), suggesting a requirement
for additional downstream residues. Moreover, the 18C-terminal
residues from the APP tail were sufficient for interaction (Fig-Developmental Cell 1ure 1D, K676-N695). An Ala scan mutagenesis of
this segment revealed an additional requirement
of Phe-689, Phe-690 and Glu-691 for interaction
(Figure 1E). Therefore, the APP sequence recog-
nized by m4 is YKFFE (residues 687-691; dashed
box in Figure 1B), in which the Lys residue is unim-
portant. This interaction was confirmed in vitro by
isothermal titration calorimetry (ITC) using purified
components. We found that a synthetic ENPTYKF-
FEQ peptide, but not a substituted ENPTAKAAEQ
variant, bound to a single site on recombinant m4
C-terminal domain with Kd = 29.6 ± 2.4 mM
(Figure 1F). Further Y2H analyses showed that
Leu could substitute for either of the two Phe, and
Tyr for the first Phe, in the YKFFE sequence, withonly minor loss of interaction with m4 (Figure 1G). Although not
exhaustive, these analyses defined a provisional motif for inter-
action with m4 as YX[FYL][FL]E. This motif has unique features
such as the [FYL] and E residues that distinguish it from other
YXXØ-type signals and probably determine specific interaction
with m4. A search of protein sequence databases using this motif
as query identified the sequences YKYLE and YRFLE from the
cytosolic tails of two other type I transmembrane proteins,
APLP1 and APLP2, respectively. We demonstrated experimen-
tally that these two sequences indeed bind to m4 (Figure 1G).
Notably, APLP1 and APLP2 are APP-related proteins that traffic
and are proteolytically processed in a manner similar to APP
(Anliker and Muller, 2006), suggesting that AP-4 might be
a common adaptor for APP family members.
The YKFFE Sequence from APP Binds to a Novel Site
on the Surface of m4
To elucidate the structural bases for the recognition of this
unique subtype of YXXØ motif, we solved the crystal structure
of the C-terminal domain of m4 (residues 185–453 of the human
protein) in complex with an ENPTYKFFEQ peptide derived from
theAPP tail at 1.6 A˚ resolution (Figures 2Aand 3A; see Figure S1A
available online; Table 1). The m4 C-terminal domain has an
immunoglobulin-like b sandwich fold consisting of 17 strands
organized into two subdomains named A and B (Figure 2A and
Figure S1A), similar to the structure of the C-terminal domain
of m2 (Figure 2B and Figure S1B) (Owen and Evans, 1998). The
overall root-mean-square deviation for 222 superimposable Ca8, 425–436, March 16, 2010 ª2010 Elsevier Inc. 427
Figure 3. Details and Verification of the Signal-Binding Site on m4
(A) Stick representation of the bound peptide TYKFFEQ (shown with carbon atoms colored yellow) superimposed on a 2Fo-Fc omit electron density map
contoured at 0.8 s.
(B) Surface complementarity between the peptide and m4. Surface colors for residues in contact with the TYKFFEQ peptide are green for hydrophobic, red for
acidic, blue for basic, and orange for uncharged polar.
(C) Alignments of the sequences containing the signal-binding site in m4 from different species and of the homologous m1A, m1B, m2, m3A, and m3B sequences
from H. sapiens. Residues in the signal-binding site in human m4 that are identical (red), conserved (orange), and nonconserved (gray) are indicated.
(D and E) Y2H assays involving coexpression of Gal4ad fused to wild-type or mutant m4 and Gal4bd fused to the APP tail were performed as described in the
legend to Figure 1. See also Figure S2.
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the ENPTYKFFEQ peptide, only the TYKFFEQ segment was
visible in the density map (Figures 2A and 3A; Figure S1A).
Unexpectedly, this segment was found to bind, in an extended
conformation, to strands 4, 5, and 6 of m4 (Figure 2A; Figure S1A),
whereas YXXØ signals bind to strands 1 and 16 of m2 (Figure 2B;
Figure S1B) (Owen and Evans, 1998). The signal-binding sites on
m4 and m2 are thus on opposite faces and separated by 30 A˚ on
the surface of the proteins (Figure 2B). Moreover, the signal-
binding site on m4 is predicted to be fully accessible for interac-
tions in the context of the whole AP-4 complex core (Figure 2C),
in contrast to that on m2, which is partially occluded by contacts
with b2 in the AP-2 core complex (Figure 2D) (Collins et al., 2002).
The area of the interface involving the signal on m4 is 426 A˚2
whereas that of an YXXØ signal from the EGF receptor bound
to m2 is 393 A˚2, as calculated by the PISA server (Krissinel and
Henrick, 2007). The m4-APP interface has substantial polar
character, with seven direct hydrogen bonds (distance% 3.1 A˚)
between peptide and protein (Figure S2). The central portion of
the peptide, comprising Tyr-687 to Phe-690, is in a b conforma-
tion. Residues 688–690 from the peptide form a b sheet
hydrogen-bonding pattern with the exposed edge of strand b4428 Developmental Cell 18, 425–436, March 16, 2010 ª2010 Elsevierspanning m4 residues 253–257 (Figure S2A). Where the N
terminus of the peptide pulls away from strand b4, a tightly
bound water molecule makes a water-mediated hydrogen
bond between the two backbones (Figure S2A). The phenolic
hydroxyl of the peptide Tyr-687 forms the shortest side-chain
to side-chain hydrogen bond in the complex with the carboxylate
of Glu-265 of m4 (Figure S2B). APP Glu-691, the penultimate
visible residue in the peptide, forms a direct and a water-medi-
ated hydrogen bond with the side chain of m4 Ser-257 (Fig-
ure S2C). The main chain carbonyl group of Glu-691 is stabilized
by a hydrogen bond with the side chain of His-256 (Figure S2C).
The peptide contains an unblocked C-terminal carboxylate,
which forms a bidentate salt bridge with the Arg-283 guanidi-
nium moiety (Figure S2D).
All three aromatic side chains in the peptide make substantial
contacts with m4. In addition to hydrogen bonding with m4
Glu-265, the peptide Tyr-687 forms hydrophobic contacts with
Leu-261 (Figures 3A and 3B; Figure S2B). The peptide Phe-689
is half buried against the side chains of m4 Phe-255, Val-259,
and Leu-261 (Figures 3A and 3B). The peptide Phe-690 is deeply
buried and surrounded by the hydrocarbon portions of m4
His-256, Thr-280, and Arg-283 (Figure 3A and 3B). The m4Inc.
Table 1. Data Collection, MAD Phasing, and Crystallographic Refinement
Crystal Native Se-Met
Construct H. sapiens m4 (160-453; C235S, C431S) H. sapiens m4 (160-453; C235S, L424M, C431S)
Space group P21 P21
Cell dimension a = 46.7 A˚, b = 56.9 A˚, c = 60.7 A˚, b = 106.5 a = 46.7 A˚, b = 57.2 A˚, c = 60.7 A˚, b = 106.3
X-ray source SER-CAT 22-ID-D GM/CA-CAT 23-ID-D
Wavelength (A˚) 1.0000 Edge = 0.9794 Peak = 0.9796 Remote = 0.9719
Resolution (A˚) 1.6 (1.66-1.6) 1.95 (2.02-1.95)
No. of reflections 39566 22201 22222 22468
Rmerge
a (%) 9.7 (44.5) 7.6 (28.9) 6.7 (28.8) 6.9 (30.4)
I/s 13.8 (1.5) 18.7 (4.6) 23.2 (4.6) 22.4 (4.6)
Data completeness (%) 97.3 (84.2) 99.4 (97.5) 99.5 (97.4) 99.4 (97.6)
Redundancy 4.4 (2.4) 7.1 (5.7) 7.1 (5.6) 7.1 (5.7)
Phasing
No. sites 4
FOM 0.41
FOM after DM 0.66
Refinement
Rfactor (%) 20.7
Rfree (%) 25.3
Rms bond angle () 1.731
Rms bond length (A˚) 0.015
The values in parentheses relate to highest resolution shells.
a Rmerge = Shkl jIhkl - < Ihkl > j / Shkl Ihkl.
Developmental Cell
Sorting of APP Mediated by AP-4Arg-283 guanidinium group forms a cation-p interaction with the
peptide Phe-690 phenyl ring (Figures 3A and 3B; Figure S2D).
The residues involved in this interaction are well conserved in
m4 orthologs from A. thaliana to H. sapiens and, surprisingly,
also in the m subunits of other AP complexes (Figure 3C). This
conservation of the m4 binding site, highlighted by analysis using
ConSurf (Landau et al., 2005) (Figure S2E), suggests that other m
subunits might also have a generally similar binding site, albeit
with key differences in detail that explain their failure to bind
the APP tail.
Consistent with a functional role for the signal-binding site on
m4, single mutation of Phe-255 to Ala or Arg-283 to Asp drasti-
cally reduced (Figure 3D), and double mutation of these residues
completely abrogated (Figure 3E), binding to the APP tail in Y2H
assays. The single Arg-283 to Asp mutation was sufficient to
render the interaction undetectable by ITC (Figure 1F). Single
mutation of His-256, Glu-265, Arg-283 to Ala had little or no
effect on the interaction, but triple mutation of these residues
greatly decreased the interaction in Y2H assays (Figures 3D
and 3E). Similarly, mutation of Ser-257 to Ala had no detectable
effect (Figure 3D); however, this mutation together with His-256
and Phe-255 to Ala completely abolished binding to the APP tail
(Figure 3E). This mutational analysis thus validated the identity of
the binding site in the m4 crystal structure as that responsible for
the Y2H and in vitro interactions.
Disruption of the YKFFE-m4 Interaction Shifts
the Distribution of APP from Endosomes to the TGN
To determine whether the YKFFE-m4 interaction was functional
in vivo, we examined the effect of disrupting it on the intracellularDevelodistribution of APP analyzed by immunofluorescence micros-
copy of HeLa cells. Under normal conditions, APP localized
mainly to endosomes (74 ± 8%, n = 11), whereas AP-4 was
largely restricted to the TGN (Figure S3A). We substituted three
Ala residues for Phe-689, Phe-690, and Glu-691 in the APP tail
in order to disrupt the m4-interacting sequence YKFFE (dashed
box in Figure 1B), while leaving intact the PTB-interacting
sequence NPTY (dashed underline in Figure 1B). We observed
that, in contrast to normal APP (APP-WT; Figures 4A–4C), this
mutant protein localized mostly to the TGN (68 ± 6%, n = 15)
(APP-3A; Figures 4D–4F). Similarly to mutation of the FFE
sequence, depletion of m4 by RNAi (Figure S3B) caused redistri-
bution of APP from endosomes (Figures 4G–4I) to the TGN
(70 ± 6%, n = 14) (Figures 4J–4L; Figures S3C), but did not alter
the distribution of other transmembrane proteins such as the
a chain of the interleukin-2 receptor (Tac) or b-secretase
(BACE1) (data not shown). Inhibition of protein synthesis by
treatment with cycloheximide (CHX) resulted in rapid disappear-
ance of APP-WT staining in both mock- and m4-depleted cells
(Figure S3C), indicating that APP localization to endosomes
and the TGN reflected transient residence, rather than long-
term accumulation, in those compartments. Taken together,
these results demonstrated that disruption of the interaction of
APP with m4 caused a shift in the steady-state distribution of
APP from endosomes to the TGN, pointing to a role of AP-4 in the
transport of APP from the TGN to endosomes. In line with this
interpretation, replacement of the m4-specific YKFFE signal for
the YXXØ-type YQRL signal of a Tac-TGN38 chimera (Humphrey
et al., 1993) redirected this protein from the TGN to endosomes
(Figure S3D).pmental Cell 18, 425–436, March 16, 2010 ª2010 Elsevier Inc. 429
Figure 4. Redistribution of APP from Endo-
somes to the TGN upon Disruption of Its
Interaction with m4
(A–F) HeLa cells were transfected with plasmids
encoding either APP-CFP (WT) (A–C) or APP-
CFP carrying the triple mutation F689A, F690A,
and E691A (3A) (D–F).
(G–L) HeLa cells were mock-transfected (G–I)
or transfected twice with siRNA directed to m4
(J–L), and then retransfected with a plasmid
encoding APP-CFP. Cells were stained for
TGN46 and examined by confocal fluorescence
microscopy. Merging red and green channels
generated the third picture on each row; yellow
indicates overlapping localization. Insets show
23 magnifications. Bars: 10 mm.
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CTF Levels and Increases Ab Secretion Due
to Enhanced g-Secretase Cleavage
Next, we examined the effect of disrupting the YKFFE-m4 inter-
action on the processing of APP. In the nonamyloidogenic
pathway, APP is initially cleaved near the middle of the Ab region
by a-secretases, leading to the production of a soluble, secreted
N-terminal fragment (sAPPa) and a transmembrane C-terminal
fragment (CTFa; also termed C83) (Figure 1A). In contrast, in
the amyloidogenic pathway, APP is cleaved at the N terminus
of Ab by b-secretase, yielding a slightly shorter sAPPb fragment
and a slightly longer CTFb fragment (also termed C99) (Fig-
ure 1A). Both CTFs are further cleavedwithin the transmembrane
domain by g-secretase into p3 and AICDg (for CTFa) and Ab and
AICDg (for CTFb) fragments (Figure 1A).
Metabolic labeling, pulse-chase analyses showed that muta-
tion of the FFE sequence had no detectable effect on transport
of APP from the ER to the Golgi complex, as evidenced by the
normal appearance of a more slowly migrating species bearing
complex carbohydrates (Figures S4A and S4B, m). Likewise,
the mutation had no effect on APP expression at the cell surface,
as assessed by biotinylation (Figure S4C). Moreover, shedding
of the sAPPa ectodomain fragment into the medium (Figure 5A,
medium) was not affected or slightly elevated by the mutation,
indicating that cleavagemediated by a-secretases and secretion
were not altered. Surprisingly, the levels of the other product of
a-secretase cleavage, CTFa, were substantially decreased by
the FFE mutation, as observed by both pulse-chase (Figure 5A,430 Developmental Cell 18, 425–436, March 16, 2010 ª2010 Elsevier Inc.cells) and immunoblot analysis (Figure 5B)
(CTFa derived from APP-3A has an intrin-
sically reduced electrophoretic mobility
due to the three-amino acid substitution).
Depletion of m4 by RNAi also decreased
the levels of CTFa, as detected by immu-
noblot analysis (Figure 5C).
Because the amyloidogenic pathway
is minor in most cells, the products of
b-secretase-mediated APP cleavage are
more difficult to detect. Despite higher
backgrounds, however, use of an anti-
body to an Ab epitope (i.e., 6E10; Fig-
ure 1A) revealed that mutation of theFFE sequence also decreased the levels of CTFb (Figure 5A,
cells, asterisk). To enhance the production of CTFb and thus
increase the sensitivity of the assay, we introduced the patho-
genic Swedish double mutation K595N/M596L (Citron et al.,
1992) in both APP-WT and APP-3A and coexpressed the mutant
proteins with excess b-secretase (BACE1) (Figure S4D, left
panel). Under these conditions, we also observed that mutation
of the FFE sequence reduced the levels of CTFb (Figure S4D,
right panel).
How could the levels of CTFa be reduced if a-secretase
cleavage was not affected by the FFE mutation? We reasoned
that turnover of CTFa by g-secretasemust be enhanced. Indeed,
addition of the g-secretase inhibitor DAPT abrogated the
decrease in steady-state CTFa levels elicited by either mutation
of the FFE sequence (Figure 5B) or depletion of m4 (Figure 5C).
Furthermore, depletion of m4 increased the secretion of the p3
and Ab peptides into the culture medium (Figures 5D–5F),
consistent with enhanced g-cleavage caused by disruption of
the YKFFE-m4 interaction.
Increased AICDg Production and Decreased
Caspase Cleavage Caused by Disruption
of the YKFFE-m4 Interaction
Enhanced g-secretase cleavage should also lead to increased
production of AICDg (Figure 1A). This fragment is normally diffi-
cult to detect because of its rapid turnover, but can be partially
stabilized by addition of a C-terminal tag (Kaether et al., 2006).
To test our prediction, we expressed in HeLa cells an APP
Figure 5. Disruption of the APP-m4 Interaction Alters CTF Levels
and p3/Ab Secretion
(A) HeLa cells transfected with HA-tagged wild-type APP (APP-WT) or APP
with the triple mutation F689A, F690A, and E691A (APP-3A) were labeled for
15 min with [35S]methionine-cysteine and chased for 0–45 min at 37C. APP
species were immunoprecipitated (IP) from cell lysates or culture media with
the indicated antibodies. Proteins were analyzed by SDS-PAGE and fluorog-
raphy.
(B and C) Anti-tail immunoblot (IB) analysis of APP and CTF species from
cells expressing APP-WT or APP-3A (B), or from mock- or m4-knockdown
(KD) cells expressing APP-WT (C), in the absence () or presence (+) of
250 nM g-secretase inhibitor DAPT.
(D)Mock- or m4-KD cells expressing APP-WTwere labeled for 4 hr at 37Cwith
[35S]methionine-cysteine, and the culture medium was subjected to immuno-
precipitation with antibodies 4G8 (recognizing both p3 and Ab) and 6E10
(recognizing only Ab). Proteins were analyzed by electrophoresis on Tricine
10%–20% acrylamide gradient gels and fluorography. The positions of molec-
ular mass markers are indicated on the left.
(E and F) Mean ± SD from three experiments like that in (D). Control: mock.
See also Figure S4.
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Sorting of APP Mediated by AP-4construct tagged at the C terminus with the cyan fluorescent
protein (APP-CFP). Immunoblot analysis using an antibody to
GFP revealed the presence of two bands in the total lysates
(Figure 6A, first lane). The upper band, enriched in the pellet (P)
fraction, corresponded to membrane-bound, full-length APP-
CFP (Figure 6A). The lower band was more abundant in the
soluble (S) fraction, as expected for cytosolic AICDg-CFP (Fig-
ure 6A). Inhibition of g-secretase by DAPT precluded AICDg-
CFP formation and increased CTFa-CFP levels (Figure 6A).
Interestingly, DAPT treatment also increased the levels of a
smaller, soluble fragment (Figure 6A, asterisk). Formation of
this fragment in DAPT-treated cells was prevented by mutation
of Asp-664 in the APP tail (Figure 6B) or by incubation with the
inhibitor Z-VAD-FMK (Figure 6C), properties that identify it asDevelothe previously described C31 caspase cleavage product (Lu
et al., 2000).
Using this experimental setup, we found that mutation of the
FFE sequence in APP (Figures 6D–6E) or depletion of m4 (Figures
6F–6G) indeed increased AICDg-CFP levels. This difference was
abolished by incubationwith DAPT, resulting in the accumulation
of equal amounts of CTFs under all conditions (Figures 6D–6G).
Intriguingly, the levels of C31 fragment in DAPT-treated cells
decreased upon disruption of this interaction for both normal
APP (Figures 6D–6G) and the APP Swedish mutant (Figure S5A).
Taken together, the results of the above biochemical analyses
indicated that disruption of the YKFFE-m4 interaction enhances
g-secretase cleavage of APP, resulting in decreased levels of
both CTFa and CTFb and elevated levels of the corresponding
p3/Ab and AICDg products. In addition, disruption of this interac-
tion decreases production of theC31 caspase cleavage product.
Similar results were obtained in experiments with H4 neuro-
glioma cells (Figures S3C, S4E, S4F, and S5B), another well-
established model system for biochemical analysis of APP
processing (Xie et al., 2005).
Nonamyloidogenic Disposal of CTF Fragments
Promoted by AP-4
Because the substrate of g-secretase is not full-length APP but
the CTFs (Xia et al., 2000), we examined the effect of disrupting
the YKFFE-m4 interaction on the fate of a recombinant CTFb
construct that mimics b-secretase-cleaved APP (Kaether et al.,
2006). Immunoblotting of HeLa cells expressing CTFb tagged
with GFP showed two species corresponding to intact CTFb
and AICDg, indicating that this construct is indeed processed
by g-secretase (Figure 7A). Treatment with DAPT prevented
AICDg formation and resulted in the appearance of CTFa and
C31 (Figure 7A). The identity of this latter fragment was con-
firmed by its absence upon mutation of the caspase cleavage
site residue Asp-664 (numbering corresponds to full-length
APP) (Figure 7A) or incubation with Z-VAD-FMK (Figure 7B).
Thus, CTFb is a substrate for a-secretases and caspase. Muta-
tion of the YKFFE sequence (Figures 7C–7D) or depletion of m4
(Figures 7E–7F) increased the levels of AICDg and decreased
the levels of C31 generated from CTFb. In addition, m4 depletion
increased Ab secretion into the medium (Figures 7G–7H). Thus,
processing of CTFb by g-secretase and caspase is also depen-
dent on the YKFFE-m4 interaction, demonstrating a role for AP-4
in the sorting of CTFb.
DISCUSSION
The recognition of the YX[FYL][FL]E motif from the cytosolic tails
of APP family members by the m4 subunit of AP-4 represents
a novel type of signal-adaptor interaction, characterized by the
distinct properties of both the motif and the binding site.
The YX[FYL][FL]E motif encompasses an YXXØmotif, charac-
teristic of signals that bind to the m1, m2, and m3 subunits of the
corresponding AP complexes (Ohno et al., 1996; Ohno et al.,
1995). However, the YKFFE sequence from APP does not bind
to these m subunits, instead binding to the m4 subunit of AP-4.
This unusual recognition pattern stems from the distinctive
features of the YX[FYL][FL]E motif. First, the N-terminal Tyr
residue (herein designated position 0 to facilitate discussion ofpmental Cell 18, 425–436, March 16, 2010 ª2010 Elsevier Inc. 431
Figure 6. Disruption of the APP-m4 Interaction Alters AICDg and C31 Levels
All experiments were performed with HeLa cells expressing normal or mutant APP constructs tagged with CFP, incubated in the absence () or presence (+) of
DAPT, and analyzed by SDS-PAGE and immunoblotting with antibody to GFP, with the variations indicated below. The positions of molecular mass markers
and different APP species are indicated.
(A) Cells expressing APP-CFP were homogenized to obtain pellet (P) and supernatant (S) fractions. m, mature; i, immature.
(B) Cells expressing normal APP-CFP (WT) or APP-CFP carrying a D664A mutation.
(C) Cells expressing normal APP-CFP were treated with 100 mM E-64, 200 mM Z-VAD-FMK, and/or 250 nM DAPT.
(D) Cells expressing normal APP-CFP (WT) or APP-CFP with the F689A, F690A, and E691A mutation (3A).
(E) Mean ± SD of AICDg and C31 levels from three experiments such as that shown in (D).
(F) Mock- or m4-depleted cells (m4 KD) expressing APP-CFP.
(G) Mean ± SD of AICDg and C31 levels from three experiments such as that shown in (F). See also Figure S5.
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Sorting of APP Mediated by AP-4the data) is quantitatively important, but not essential for interac-
tion with m4. Second, the presence of Phe, Tyr, or Leu residues at
position +2 is required for interaction with m4, but strongly disfa-
vors interactions with m1, m2, and m3 (Ohno et al., 1998). This
particular feature likely determines the lack of interaction of the
APP tail with m subunits other than m4. Finally, another key deter-
minant of specific recognition by m4 is an additional Glu residue
at position +4. Hence, the new motif defined here is a pentapep-
tide in which the [FYL], [FL], and E positions aremore critical than
the Tyr at position 0 for interaction with AP-4.
Other proteins reported to interact with AP-4 (Matsuda et al.,
2008; Simmen et al., 2002; Yap et al., 2003) do not have
sequences fitting the YX[FYL][FL]E motif. However, some of
these proteins have scattered Tyr and Phe residues that are
required for interaction with m4 (Matsuda et al., 2008; Yap et al.,
2003). In addition, a combinatorial screen for random sequences
that bind to m4 revealed a strong preference for peptides432 Developmental Cell 18, 425–436, March 16, 2010 ª2010 Elsevierenriched in Tyr and Phe, most often as a pair (Aguilar et al.,
2001). This indicates that Tyr and Phe residues in configurations
other than YX[FYL][FL]E might also participate in AP-4 binding. It
remains to be determined whether these represent variations on
the motif or entirely different interaction determinants.
Given the unique features of the YX[FYL][FL]E motif, we
expected that its binding site on m4 would exhibit substantial
differences relative to that of YXXØ signals on m2 (Owen and
Evans, 1998). We were surprised, however, that the m4 binding
site was distinct not just in terms of the residues and interactions
involved, but also in its location on a face opposite to that of
the m2 binding site. This location of the m4 binding site has impor-
tant implications for the mechanism of signal recognition by
AP-4. In the crystal structure of the AP-2 core, the signal-binding
site on m2 is partially occluded by contacts with the b2 subunit
(Collins et al., 2002). Therefore, binding of YXXØ signals to m2
requires a conformational change to displace the C-terminalInc.
Figure 7. Altered Processing of CTFb upon Disrup-
tion of the YKFFE-m4 Interaction
Experiments were performed as in Figure 6, with the
variations indicated below. The positions of molecular
mass markers and different APP species are indicated.
(A) Cells expressing normal CTFb-GFP (WT) or CTFb-GFP
carrying a D664A mutation.
(B) Cells expressing normal CTFb-GFP were treated with
100 mM E-64, 200 mM Z-VAD-FMK, and/or 250 nM DAPT.
(C) Cells expressing normal CTFb-GFP (WT) or CTFb-GFP
with the triple mutation, F689A, F690A, and E691A (3A).
(D) Mean ± SD of AICDg and C31 levels from three exper-
iments such as that shown in (C).
(E) Mock- or m4-depleted cells (m4 KD) expressing
CTFb-GFP.
(F) Mean ± SD of AICDg and C31 levels from three exper-
iments such as that shown in (E).
(G) Mock- or m4-depleted cells expressing normal
CTFb-GFP were labeled for 4 hr at 37C with [35S]methio-
nine-cysteine, and the culture medium was subjected to
immunoprecipitation with antibody 6E10 to Ab. Proteins
were analyzed by electrophoresis on Tricine 10%–20%
acrylamide gradient gels and fluorography. An aliquot of
the culture media (total) is shown as loading control.
(H) Mean ± SD from four experiments like that in (G).
Control: mock.
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Sorting of APP Mediated by AP-4domain of m2 from the core and thus expose the signal-binding
site (Collins et al., 2002). This conformational change could be
triggered by phosphorylation of residues in the hinge that links
the N- and C-terminal domains of m2 (Olusanya et al., 2001;
Ricotta et al., 2002). In contrast, modeling of the AP-4 core after
the homologous AP-2 core predicts that the signal-binding site
on m4 is fully exposed on the surface of the complex and there-
fore does not require displacement of the C-terminal domain for
binding. Hence, the signal-adaptor interactions involving m2 and
m4 might also differ on how they are regulated.
A key criterion to establish the functional relevance of a signal-
adaptor interaction in vivo is that its disruption should alter the
localization and trafficking of signal-bearing cargo proteins. To
test this for the interaction described here, we disrupted it by
either mutating the signal or depleting cells of m4. Similar results
were obtained with both manipulations, ruling out indirect
effects. A visible consequence of this disruption was a greatly
reduced localization of APP to endosomes and increased
labeling of the TGN. This labeling rapidly disappeared upon
treatment of the cells with cycloheximide, indicating that it is
not due to accumulation of APP within the TGN but to transientDevelopmental Cell 18, 4residence in this compartment prior to transport
to the cell surface and secretase-mediated
breakdown. Faint residual staining of endo-
somes could be seen in some cells upon disrup-
tion of the YKFFE-m4 interaction; this could
result from sorting mediated by interaction of
the NPXY motif in APP with PTB-domain con-
taining proteins at the plasma membrane or
the TGN (Small and Gandy, 2006). Since AP-4
has been localized to the TGN by both immuno-
fluorescence (Dell’Angelica et al., 1999; Hirst
et al., 1999; Simmen et al., 2002) and immunoe-lectron microscopy (Hirst et al., 1999), the most parsimonious
interpretation of our data is that AP-4 mediates biosynthetic
sorting of a population of APP and/or CTFs from the TGN to
endosomes.
Since the processing of APP by the nonamyloidogenic and
amyloidogenic pathways is highly dependent on its intracellular
itinerary (Small and Gandy, 2006), we anticipated that altering
the trafficking of APP by perturbation of its interaction with
AP-4 could change its processing pattern. We found that disrup-
tion of the YKFFE-m4 interaction had no effect on APP export
from the ER to the Golgi complex, transport to the plasma
membrane, and a-secretase-catalyzed production of sAPPa,
which occurs on theway from the TGN to the plasmamembrane,
or at the plasma membrane itself (Schobel et al., 2008; Skovron-
sky et al., 2000). This disruption, however, caused enhanced
cleavage of CTF products by g-secretase, an enzyme that acts
at various intracellular compartments, including the TGN, endo-
somes, and the plasma membrane (Baulac et al., 2003; Kaether
et al., 2006; Xia et al., 2000). As a consequence, there was
increased production of p3 and AICDg fragments, and, most
significantly, of the pathogenic Ab peptide.25–436, March 16, 2010 ª2010 Elsevier Inc. 433
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ated remains controversial. Some studies have led to the conclu-
sion that Ab is produced in the Golgi complex and/or the late
secretory pathway (Thinakaran et al., 1996; Xia et al., 2000;
Xu et al., 1997), a notion that is consistent with the localization
of at least a fraction of the b- and g-secretases to this part of
the pathway (Baulac et al., 2003; Skovronsky et al., 2000; Vassar
et al., 1999; Xia et al., 2000) and with the detection of complexes
between CTFs and g-secretase in Golgi/TGN fractions (Xia et al.,
2000). Others, however, have presented evidence in favor of Ab
production in endosomes (Haass et al., 1992; Koo and Squazzo,
1994; Perez et al., 1999; Perez et al., 1996). Our observations
support the former scenario by showing that decreased endoso-
mal localization of APP results in increased g-secretase-medi-
ated cleavage and Ab secretion.
AP-4-mediated diversion from the secretory pathway might
serve the purpose of sequestering a fraction of APP or, more
likely, removing CTFs away from g-secretase, thus reducing
the generation of Ab. This diversion is likely a step toward the
eventual transport of APP and/or CTFs to lysosomes for degra-
dation by acid hydrolases (Caporaso et al., 1992; Haass et al.,
1992). Our results also indicate that, conversely to Ab, the C31
caspase-cleavage product of APP (Lu et al., 2000) arises upon
AP-4-dependent transport to endosomes, consistent with the
presence of caspase activity in association with endosomes
(Cosulich et al., 1997).
In conclusion, our results suggest that AP-4 exerts a protective
effect, guarding against excessive Ab production. Altered ex-
pression of other trafficking factors has been associated with
increased Ab production and greater risk of AD (Small and
Gandy, 2006). Defects in AP-4 should therefore be considered
another potential risk factor for AD.
EXPERIMENTAL PROCEDURES
Recombinant DNAs, Site-Directed Mutagenesis, and Y2H Assays
For all APP constructs generated in this study, a cDNA encoding an
N-terminal, HA-tagged full-length human APP695 (GeneCopoeia) was used
as template. To generate a GST-fusion construct with the C-terminal domain
of human m4, the sequence encoding residues 160–453 was obtained by
PCR amplification and cloned in-frame into the EcoRI and SalI sites of
pGST-Parallel-1 (Sheffield et al., 1999). The substitutions C235S and C431S
were introduced to produce protein for ITC and protein crystallization. Single
or multiple amino acid substitutions and stop codons were introduced using
the QuikChange mutagenesis kit (Stratagene). Y2H assays were performed
as previously described (Aguilar et al., 2001; Ohno et al., 1996; Ohno et al.,
1995).
Transfection and RNAi
Transfections were carried out using Lipofectamine 2000 (Invitrogen) for 1 hr at
37C in the absence of FBS. Cells were analyzed 8–16 hr after transfection.
For some experiments, cells were incubated for 16 hr with 250 nM DAPT
(Sigma-Aldrich), 100 mM E-64 (EMD Chemicals), or 200 mM Z-VAD-FMK
(EMD Chemicals). RNAi of human m4 was performed using the siRNA GUCUC
GUUUCACAGCUCUG (Dharmacon) (Janvier and Bonifacino, 2005).
Antibodies
Mouse monoclonal antibodies used were 22C11 to N-terminal region of APP
(Millipore), 4G8 and 6E10 to APP (Covance), clone 32 to the 3 subunit of
AP-4 and clone 14 to EEA1 (BD Biosciences), 7G7 to a Tac lumenal epitope
(Humphrey et al., 1993), AC-40 to b-actin (Sigma-Aldrich), and anti-GFP conju-
gated to horseradish peroxidase (Miltenyi Biotec). Polyclonal antibodies used
were rabbit anti-GFP (R. Hegde, NICHD, NIH), rabbit anti-3 subunit of AP-4434 Developmental Cell 18, 425–436, March 16, 2010 ª2010 Elsevier(W. Smith, NICHD, NIH), rabbit anti-m4 subunit of AP-4 (M. S. Robinson,
University of Cambridge, UK), rabbit anti-APP tail (CT695, Invitrogen), rabbit
anti-HA epitope (ABR-OPA1-10980; Affinity BioReagents), sheep anti-
TGN46 and -TGN38 (Serotec), and human anti-EEA1 (A. Gonza´lez, Pontificia
Universidad Cato´lica, Chile).
Other Procedures
Immunofluorescence microscopy, SDS–PAGE, immunoblotting, immunopre-
cipitation, and fluorography were performed as previously described
(Mardones et al., 2007) (see also Supplemental Experimental Procedures).
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